Pharmaceuticals
FTC to sue drug middlemen over prices of medications including insulin
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year 2025 Request for the Federal Trade Commission,” in Rayburn Building on Wednesday, May 15, 2024. Tom Williams | CQ-Roll Call, Inc. | Getty Images The Federal Trade Commission is planning to sue three large U.S. […]
Read More
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition. Semaglutide, which is present in weight loss drugs including Novo Nordisk’s Ozempic […]
Read More
CNBC Daily Open up: Tesla soars, S&P closes over 5,500
This report is from today’s CNBC Daily Open, our intercontinental marketplaces e-newsletter. CNBC Everyday Open delivers traders up to pace on every little thing they need to know, no matter wherever they are. Like what you see? You can subscribe here. Traders function on the flooring of the New York Inventory Trade during morning investing on […]
Read More
FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Rally in markets: Stocks were higher across the board Tuesday afternoon, led by the Nasdaq Composite , which added 0.7% and was on pace for back-to-back […]
Read More
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Scott Olson | Getty Images The Food and Drug Administration on Tuesday approved Eli Lilly‘s Alzheimer’s drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The […]
Read More
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC. A day earlier, the pharmaceutical giant’s stock had closed 6% higher after its […]
Read More
Walgreens slashes profit guidance, citing ‘challenging’ environment for consumers and pharmacies
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a “challenging” environment for pharmacies and U.S. consumers. The […]
Read More
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023. Chris Kleponis | Bloomberg | Getty Images The Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of this year, lowering costs […]
Read More
Novo Nordisk’s Wegovy weight loss drug approved in China
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world’s second largest economy. China’s National Medical Products Administration “recently” […]
Read More
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies. Demand for […]
Read More